CBGL — Cannabis Global,. Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.65m
- $8.45m
- $1.60m
Annual income statement for Cannabis Global,., fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2017 August 31st | 2018 August 31st | 2019 August 31st | 2020 August 31st | 2021 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.027 | 1.6 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 0.002 | 0.184 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.001 | 0.051 | 0.382 | 3.61 | 3.58 |
| Operating Profit | -0.001 | -0.051 | -0.382 | -3.58 | -1.98 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.008 | -0.087 | -0.39 | -4.93 | -8.12 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.008 | -0.087 | -0.39 | -4.93 | -8.12 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.008 | -0.087 | -0.39 | -4.93 | -7.83 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.008 | -0.087 | -0.39 | -4.93 | -7.83 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.012 | -0.045 | -0.291 | -0.134 |